Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP-binding cassette sub-family D member 3 (ABCD3, also known as PMP70) is a peroxisomal membrane transporter belonging to the ABC transporter superfamily[1][4]. It mediates peroxisomal import of specific fatty acyl-CoAs, including long-chain and branched-chain fatty acids, dicarboxylic fatty acids, and bile acid precursors, facilitating their subsequent β-oxidation in the peroxisome[1][2][4][5]. Structurally, ABCD3 is a half-transporter that forms functional homo- or heterodimers in the peroxisomal membrane[3][4]. Mutations in ABCD3 can lead to peroxisomal metabolic disorders, including rare cases of congenital bile acid synthesis defect and potentially contribute to the spectrum of Zellweger syndrome[1][2][4]. The protein plays a critical role in maintaining lipid metabolic balance and peroxisome function within cells[2][4]. No approved or clinically established drugs specifically target ABCD3, and its main human disease links are genetic in nature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-binding cassette sub-family D member 3 (ABCD3).